PIERIS PHARMACEUTICALS, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2015 to Q4 2017

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Pieris Pharmaceuticals, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q4 2017.
  • Pieris Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2017 was $1.08M, a 126% increase year-over-year.
  • Pieris Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2017 was $3.05M, a 59.9% increase year-over-year.
  • Pieris Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.35M, a 23.9% decline from 2022.
  • Pieris Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.4M, a 15.6% decline from 2021.
  • Pieris Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.22M, a 2.46% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2017 $3.05M $1.08M +$605K +126% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 $2.44M $650K +$204K +45.7% Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $2.24M $560K -$52K -8.49% Apr 1, 2017 Jun 30, 2017 10-Q 2017-08-11
Q1 2017 $2.29M $752K +$384K +104% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $1.91M $479K +$137K +40.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-15
Q3 2016 $1.77M $446K +$108K +32.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $1.66M $612K +$344K +128% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-11
Q1 2016 $1.32M $368K +$151K +69.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $1.16M $341K Oct 1, 2015 Dec 31, 2015 10-K 2017-03-30
Q3 2015 $338K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $268K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 $217K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.